State regulators determined the deal would not curb health insurance market competition, though New York is mandating the insurers still offer private Medicare products and avoid cutting benefits. The New York Department of Financial Services outlined the conditions in a letter to Aetna Monday.
Aetna now has 90 percent of required state approvals, an Aetna spokesperson told Bloomberg. New York’s conditional approval hinges on a sign-off from the U.S. Department of Justice.
Aetna met with top DOJ officials Friday to present the auction of its Medicare Advantage assets in hopes of pacifying antitrust concerns. The DOJ is currently reviewing the deal.
More articles on payer issues:
Conn. senator urges Cigna, Aetna to stay in state
Presbyterian Health Plan exits ACA exchange
Michigan insurers seek up to 39% premium rate increases
